Susquehanna International Group, LLP T2 Biosystems, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$0.36 - $0.57 $576 - $911	-1,600 Reduced 8.16%	18,000 $9,000
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $6,210 - $12,690	-13,500 Reduced 40.79%	19,600 $10,000
Q2 2021 Aug 11, 2021	SELL	$1.04 - $1.69 $109,824 - $178,464	-105,600 Reduced 76.14%	33,100 $39,000
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $101,244 - $290,693	76,700 Added 123.71%	138,700 $225,000
Q3 2020 Nov 16, 2020	BUY	$1.15 - $2.1 $3,449 - $6,300	3,000 Added 5.08%	62,000 $84,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.67 $3,216 - $11,189	6,700 Added 12.81%	59,000 $75,000
Q3 2019 Nov 14, 2019	SELL	$0.58 - $3.01 $174 - $902	-300 Reduced 0.57%	52,300 $131,000
Q2 2019 Aug 14, 2019	BUY	$1.47 - $3.16 $38,367 - $82,476	26,100 Added 98.49%	52,600 $88,000
Q1 2019 May 15, 2019	SELL	$2.56 - $4.48 $289,536 - $506,688	-113,100 Reduced 81.02%	26,500 $70,000
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $552,225 - $886,150	92,500 Added 196.39%	139,600 $1.08 Million
Q1 2018 May 15, 2018	BUY	$4.21 - $7.0 $52,204 - $86,800	12,400 Added 35.73%	47,100 $306,000
Q4 2017 Feb 14, 2018	BUY	$3.73 - $4.6 $129,431 - $159,620	34,700	34,700 $143,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.